Driving Innovation for Better Health Outcomes
At Leobery Pharmaceutical Industries LLC, R&D is the cornerstone of our commitment to advancing global healthcare. We invest in cutting-edge science and breakthrough technologies to discover, develop, and deliver life-changing medicines across a broad range of therapeutic areas.
Our R&D Mission
To accelerate scientific innovation that meets unmet medical needs through safe, effective, and accessible pharmaceutical solutions.
Key Areas of Focus
Chronic & Lifestyle Diseases – Diabetes, hypertension, cardiovascular disorders
Infectious Diseases – Antibiotic resistance, antivirals, and emerging infections
Oncology – Targeted therapies and supportive cancer care
CNS Disorders – Neurological and psychiatric treatment innovation
Pediatrics & Geriatrics – Age-specific drug development and formulations
Capabilities & Strengths
Formulation Development – Immediate release, sustained release, and novel drug delivery systems
Bioequivalence Studies – In-house or partnered centers for clinical trials and data analysis
Regulatory Submissions – Expertise in ANDA, CTD/eCTD formats for global markets
Technology Platforms – Use of nanotechnology, liposomal drug delivery, and sustained-release mechanisms
Collaborative Innovation
We believe that partnerships accelerate progress. Leobery collaborates with:
Global academic and clinical research institutions
Contract Research Organizations (CROs)
Biotech startups and technology innovators
Pipeline & Progress
Our expanding pipeline includes:
Generic drug launches in regulated and emerging markets
New chemical entity (NCE) research in select therapeutic segments
Lifecycle management of existing molecules through novel combinations and delivery systems
Quality & Compliance
All R&D activities adhere to ICH-GCP, GLP, and local regulatory norms, ensuring scientific rigor, ethical compliance, and patient safety.
